Decoy Therapeutics (DCOY) Receivables - Net (2016 - 2023)
Decoy Therapeutics (DCOY) posted quarterly Receivables - Net of $130000.0 for Q2 2023, down 91.88% year-over-year from $1.6 million in Q2 2022, and little changed quarter-over-quarter from $130000.0 in Q1 2023.
Decoy Therapeutics (DCOY) Receivables - Net (2016 - 2023) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Receivables - Net for 8 consecutive years, with $130000.0 the latest figure, recorded in Q2 2023.
- In Q2 2023, Receivables - Net fell 91.88% year-over-year to $130000.0; the TTM figure through Jun 2023 stood at $130000.0 (down 91.88% YoY), while the FY2022 annual figure was $1.6 million, changed N/A from the prior year.
- Receivables - Net held at $130000.0 in Q2 2023 per DCOY's latest filing, from $130000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $4.8 million in Q2 2021 and bottomed at $9069.0 in Q1 2019.
- Historically, Receivables - Net has averaged $1.8 million across 5 years, with a median of $1.6 million in 2022.
- Annual changes were most pronounced in 2020 — Receivables - Net surged 6418.13% — and 2023, when it slumped 91.88%.
- Decoy Therapeutics' Receivables - Net stood at $28278.0 in 2019, then jumped by 13536.03% to $3.9 million in 2020, then plunged by 45.54% to $2.1 million in 2021, then dropped by 23.31% to $1.6 million in 2022, then slumped by 91.93% to $130000.0 in 2023.
- Business Quant data shows DCOY's Receivables - Net at $130000.0 in Q2 2023, $130000.0 in Q1 2023, and $1.6 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Decoy Therapeutics | 1.76 Mn | 1.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 130,000.00 |
| Jun 30, 2023 | 130,000.00 |
| Mar 31, 2023 | 130,000.00 |
| Mar 31, 2023 | 130,000.00 |
| Dec 31, 2022 | 1.61 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 1.60 Mn |
| Sep 30, 2022 | 1.60 Mn |
| Jun 30, 2022 | 1.60 Mn |
| Jun 30, 2022 | 1.60 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Sep 30, 2021 | 2.10 Mn |
| Sep 30, 2021 | 2.10 Mn |
| Jun 30, 2021 | 4.80 Mn |
| Jun 30, 2021 | 4.80 Mn |
| Mar 31, 2021 | 4.22 Mn |
| Mar 31, 2021 | 4.22 Mn |
| Dec 31, 2020 | 3.86 Mn |
| Dec 31, 2020 | 3.86 Mn |